Table 4.
Medication | Treatment goals | Intensification of treatment during standardisation | Intensification of treatment at follow-ups |
---|---|---|---|
Antidiabetics | HbA1c ≤48 mol/mol | HbA1c >64 mmol/L or 5 mmol/mol increment | HbA1c >58 mmol/L or 5 mmol/mol increment |
Antihypertensive | BP ≤130/80 mm Hg | BP >150/95 mm Hg | BP >140/85 mm Hg |
Antilipids | LDL ≤2.0 mmol/L TG ≤5.0 mmol/L |
LDL >2.0 mmol/L TG >5.0 mmol/L |
LDL >2.0 mmol/L TG >5.0 mmol/L |
The table shows treatment goals for the U-TURN intervention and intensification of treatment. If the treatment target is reached, the dose of the compound is halved at the following control time point (3 months later). In case of unchanged values or an additional drop, the compound is then discontinued.
BP, blood pressure; HbA1c, glycated haemoglobin; LDL, low-density lipoproteins; TG, triglycerides.